An update on the genetics of pheochromocytoma.
Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are rare neuroendocrine tumors. About 30% or more of them are thought to be of inherited origin due to germ-line mutations in at least 10 well-characterized genes. There are data linking specific genotypes of these tumors to specific locations, typical biochemical phenotypes or future clinical behaviors. Conversely, clinical features, catecholamine production and immunohistochemistry evaluation can help with the proper order of genetic testing for PHEO and PGL. The identification of a germ-line mutation can lead to an early diagnosis, appropriate treatment, regular surveillance and better prognosis not only for the patient but also for their family members. Moreover, the latest discoveries in molecular pathogenesis of these tumors will provide an important basis for future personalized therapy.
Third Department of Internal Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
D
D
Karasek
U
U
Shah
Z
Z
Frysak
C
C
Stratakis
K
K
Pacak
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D002395:Catecholamines / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D040941:Heredity; D006801:Humans; D010236:Paraganglioma, Extra-Adrenal / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D018579:Patient Selection; D010641:Phenotype; D010673:Pheochromocytoma / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D057285:Precision Medicine; D011237:Predictive Value of Tests; D011379:Prognosis
D002395:Catecholamines